Skip to main content
News PageStrata Oncology

Strata Oncology Expands Strata PATH Trial with Two New Partners

By May 25, 2022May 27th, 2022No Comments

Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced that two new health system partners have joined the Strata Precision Indications for Approved THerapies (Strata PATH) trial. The University of Wisconsin Carbone Cancer Center and the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham will join Ohio-based Kettering Health Cancer Center in bringing this innovative trial to both early-stage and late-stage patients with cancer.

Read Article